Biosimilars in Developed and Developing East and Southeast Asian Countries: Japan, South Korea, and Malaysia—Overview, Evolution, and Regulations Assessment
Table 6
DCA approved biosimilars in Malaysia.
Product name
Active substance
Therapeutic area
Authorization date
Manufacturer/company name
SciTropin
Somatropin
Growth disturbance in children and growth hormone deficiency in adults
Aug. 2010
Sandoz
Binocrit
Epoetin alfa
Renal anemia, cancer, and predonation preparation for autologous and allogeneic blood transfusion
